Lipoprotein-Associated Phospholipase A <sub>2</sub> , High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) StudyChristie M. Ballantyne, A. Richey Sharrett, Ron C. Hoogeveen et al.|Circulation|2004Cited by 617
Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Ischemic Stroke in Middle-aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) StudyChristie M. Ballantyne, Eric Boerwinkle, Kenneth K. Wu et al.|Archives of Internal Medicine|2005Cited by 280
Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial DiseaseEhrin J. Armstrong, John R. Laird, Heejung Bang et al.|Journal of the American Heart Association|2014Cited by 243
Association Between Statin Medications and Mortality, Major Adverse Cardiovascular Event, and Amputation-Free Survival in Patients With Critical Limb IschemiaGregory G. Westin, John R. Laird, Ehrin J. Armstrong et al.|Journal of the American College of Cardiology|2013Cited by 188
Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial diseaseEhrin J. Armstrong, John R. Laird, David R. Anderson et al.|Journal of Vascular Surgery|2015Cited by 75